Prognosis
What You Need to Know About Moderna’s New ‘Bivalent’ Covid Vaccine
The shot engineered to take on world’s most widespread strain
This article is for subscribers only.
Moderna Inc. has just received approval from the UK for a Covid-19 booster shot that targets omicron, the version of the virus that’s now the world’s most widespread. The snappily-named Spikevax Bivalent Original/Omicron has been given the green light for use in the UK and is expected to be rolled out in other countries soon.
Read More: UK Grants World's First Approval for Moderna's Omicron Covid Vaccine